Navigation Links
Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference
Date:5/13/2009

NEW BRUNSWICK, N.J., May 13 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Deutsche Bank 34th Annual Health Care Conference on Tuesday, May 19th, at the InterContinental Boston hotel in Boston. Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group for Johnson & Johnson, will represent the Company in a session scheduled at 10:50 a.m. (Eastern Time).

This broadcast will be available to interested investors and parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Johnson & Johnson to Host Analyst Conference Call To Review Six-Month Trial Results From NEVO RES I
2. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
3. Johnson & Johnson to Participate in Bank of America and Merrill Lynch 2009 Health Care Conference
4. Weill Cornell and Cornells Johnson School present first annual business and medicine symposium
5. Johnson & Johnson to Webcast Annual Meeting of Shareholders
6. Johnson & Johnson Reports 2009 First-Quarter Results:
7. Trust for Americas Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America
8. Practice Greenhealth Enters Partnership with Johnson & Johnson for Health Care Sustainability Research and Training
9. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress
10. Johnson & Johnson to Participate in the 29th Annual Cowen & Company Health Care Conference
11. Johnson Institute Transfers Key Programs and Products to Hazelden Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: